Article Details

Glioblastoma Multiforme Treatment Segmentation, Growth Factors and Upcoming Trends by 2032

Retrieved on: 2022-10-20 16:09:13

Tags for this article:

Click the tags to see associated articles and topics

Glioblastoma Multiforme Treatment Segmentation, Growth Factors and Upcoming Trends by 2032. View article details on hiswai:

Excerpt

In April 2021, Lineage Cell Therapeutics signed an agreement with Immunomic Therapeutics to treat glioblastoma multiforme.

Article found on: www.newstrail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up